août 2013 — Single-domain antibody-based and linker-free bispecific antibodies targeting Fc\gammaRIII induce potent antitumor activity without recruiting regulatory T cells.. Molecular Cancer Therapeutics vol. 12, n° 8, dir. {American Association for Cancer Research} p. 1481-1491
,